Clinical Trials Logo

Optic Neuropathy clinical trials

View clinical trials related to Optic Neuropathy.

Filter by:

NCT ID: NCT02982499 Terminated - Optic Neuropathy Clinical Trials

Biomechanics of Optic Neuropathy

Start date: September 2016
Phase:
Study type: Observational

The participant is being asked to be a subject in this research study because the participant may have a disorder that can cause optic nerve damage and impairment of his/her visual function which is called optic neuropathies (ON). Optic neuropathy refers to damage to the optic nerve (a "cable" connecting the eyes and the brain to transmit the visual signals) due to any cause.In this study, the investigator is using magnetic resonance imaging (MRI) and ophthalmic measures such as optic coherent tomography(OCT), which are non-invasive imaging tests to measure the changes in eye globe shape ,the flow of blood and brain fluid. It is hoped that this study will provide new knowledge that may allow the investigator to better understand the cause of symptoms associated with optic neuropathy and ways to better monitor what is happening.

NCT ID: NCT02638714 Recruiting - Optic Neuropathy Clinical Trials

Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells

Start date: April 2013
Phase: Phase 1/Phase 2
Study type: Interventional

A single arm, single center trial to assess the safety and efficacy of restoring function in damaged optic nerves using autologous purified populations of bone-marrow derived stem cells (BM-SCs) through a 24 month follow up period.

NCT ID: NCT02612571 Completed - Glaucoma Clinical Trials

Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players

Start date: July 2015
Phase: N/A
Study type: Observational

The purpose of the present study is to compare rates of glaucomatous optic neuropathy in professional wind versus non-wind instrument players in the Philadelphia Orchestra. A secondary objective is to evaluate intra-ocular pressure and choroidal thickness of wind instrument players under variable playing conditions.

NCT ID: NCT01331616 Withdrawn - Glioblastoma Clinical Trials

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Start date: March 2011
Phase: Early Phase 1
Study type: Interventional

Does treatment with bevacizumab (Avastin) in combination with prior or current radiotherapy lead to optic neuropathy?

NCT ID: NCT01166594 Completed - Glaucoma Clinical Trials

Use of Bevacizumab in Trabeculectomy Surgery

Start date: June 2010
Phase: Phase 4
Study type: Interventional

When a patient with glaucoma who has a pressure that is too high and causing damage to their vision, despite receiving the maximum amount of medication that can be tolerated, the decision is made to have glaucoma surgery. Trabeculectomy is the most common form of glaucoma surgery used to treat open angle glaucoma. During trabeculectomy, an opening is created in the eye and partially covered with a flap of tissue. This new opening allows fluid to drain out of the eye bypassing the clogged drainage channels that are malfunctioning in patients with glaucoma. Studies have found that trabeculectomy significantly reduces vision loss and lowers eye pressure. However, many people need another trabeculectomy or other glaucoma surgery because the surgery may fail either early or much later because the body closes the drain created by the surgeon. The surgery is also less likely to work in patients with darker pigmentation, children who have congenital glaucoma, people with difficult to control glaucoma with new blood vessels growing on the iris, diabetes or persons with prior eye surgery. As a result, the investigators need to find ways to improve the longterm survival of trabeculectomy surgery in all patients.